The Role of Catheter-Directed CT-Angiography in Radioembolisation

Overview

Journal Cardiovasc Intervent Radiol

Specialty Cardiology & Vascular Diseases

Date 2022 May 20

PMID 35595985

Authors

Kun Da Zhuang

Aaron Kian-Ti Tong

David Chee Eng Ng

Kiang Hiong Tay

Affiliations

Soon will be listed here.

Abstract

Radioembolisation is an established transarterial therapy for hepatocellular carcinoma and liver metastasis. Success of radioembolisation depends on meticulous angiography and accurate dosimetry. Intra-procedure catheter-directed CT-angiography is commonly performed to improve the efficacy and safety of radioembolisation. This review article will (1) introduce the differences between cone beam CT and hybrid angiography-CT, and (2) describe the benefits of catheter-directed CT-angiography in radioembolisation from both an interventional radiology and nuclear medicine perspective.

References

Salem R, Lewandowski R, Kulik L, Wang E, Riaz A, Ryu R . Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology. 2010; 140(2):497-507.e2. PMC: 3129335. DOI: 10.1053/j.gastro.2010.10.049. View

Salem R, Gordon A, Mouli S, Hickey R, Kallini J, Gabr A . Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma. Gastroenterology. 2016; 151(6):1155-1163.e2. PMC: 5124387. DOI: 10.1053/j.gastro.2016.08.029. View

Louie J, Kothary N, Kuo W, Hwang G, Hofmann L, Goris M . Incorporating cone-beam CT into the treatment planning for yttrium-90 radioembolization. J Vasc Interv Radiol. 2009; 20(5):606-13. DOI: 10.1016/j.jvir.2009.01.021. View

Iwazawa J, Ohue S, Hashimoto N, Muramoto O, Mitani T . Survival after C-arm CT-assisted chemoembolization of unresectable hepatocellular carcinoma. Eur J Radiol. 2012; 81(12):3985-92. DOI: 10.1016/j.ejrad.2012.08.012. View

Pung L, Ahmad M, Mueller K, Rosenberg J, Stave C, Hwang G . The Role of Cone-Beam CT in Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. J Vasc Interv Radiol. 2017; 28(3):334-341. DOI: 10.1016/j.jvir.2016.11.037. View

Tanaka T, Arai Y, Inaba Y, Inoue M, Nishiofuku H, Anai H . Current role of hybrid CT/angiography system compared with C-arm cone beam CT for interventional oncology. Br J Radiol. 2014; 87(1041):20140126. PMC: 4453145. DOI: 10.1259/bjr.20140126. View

Tacher V, Radaelli A, Lin M, Geschwind J . How I do it: Cone-beam CT during transarterial chemoembolization for liver cancer. Radiology. 2015; 274(2):320-34. PMC: 4314294. DOI: 10.1148/radiol.14131925. View

Nakamura Y, Higaki T, Honda Y, Tatsugami F, Tani C, Fukumoto W . Advanced CT techniques for assessing hepatocellular carcinoma. Radiol Med. 2021; 126(7):925-935. DOI: 10.1007/s11547-021-01366-4. View

Kim S, Ando K, Mita K, Fuki S, Ikawa H, Kanbara Y . Superiority of CT arterioportal angiography to contrast-enhanced CT and MRI in the diagnosis of hepatocellular carcinoma in nodules smaller than 2 cm. Oncology. 2007; 72 Suppl 1:58-66. DOI: 10.1159/000111708. View

10.

Hermann A, Dieudonne A, Ronot M, Sanchez M, Pereira H, Chatellier G . Relationship of Tumor Radiation-absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with Y in the SARAH Study. Radiology. 2020; 296(3):673-684. DOI: 10.1148/radiol.2020191606. View

11.

Chung J, Kim H, Yoon J, Lee H, Jae H, Lee W . Transcatheter arterial chemoembolization of hepatocellular carcinoma: prevalence and causative factors of extrahepatic collateral arteries in 479 patients. Korean J Radiol. 2006; 7(4):257-66. PMC: 2667612. DOI: 10.3348/kjr.2006.7.4.257. View

12.

Burgmans M, Kao Y, Irani F, Dames E, Teo T, Goh A . Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe. J Vasc Interv Radiol. 2012; 23(10):1294-301. DOI: 10.1016/j.jvir.2012.07.009. View

13.

Abdelmaksoud M, Louie J, Kothary N, Hwang G, Kuo W, Hofmann L . Embolization of parasitized extrahepatic arteries to reestablish intrahepatic arterial supply to tumors before yttrium-90 radioembolization. J Vasc Interv Radiol. 2011; 22(10):1355-62. DOI: 10.1016/j.jvir.2011.06.007. View

14.

Moustafa A, Aal A, Ertel N, Saad N, DuBay D, Saddekni S . Chemoembolization of Hepatocellular Carcinoma with Extrahepatic Collateral Blood Supply: Anatomic and Technical Considerations. Radiographics. 2017; 37(3):963-977. DOI: 10.1148/rg.2017160122. View

15.

Riaz A, Lewandowski R, Kulik L, Mulcahy M, Sato K, Ryu R . Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review. J Vasc Interv Radiol. 2009; 20(9):1121-30. DOI: 10.1016/j.jvir.2009.05.030. View

16.

Leong Q, Lai H, Lo R, Teo T, Goh A, Chow P . Radiation dermatitis following radioembolization for hepatocellular carcinoma: a case for prophylactic embolization of a patent falciform artery. J Vasc Interv Radiol. 2009; 20(6):833-6. DOI: 10.1016/j.jvir.2009.03.011. View

17.

Burgmans M, Too C, Kao Y, Goh A, Chow P, Tan B . Computed tomography hepatic arteriography has a hepatic falciform artery detection rate that is much higher than that of digital subtraction angiography and 99mTc-MAA SPECT/CT: implications for planning 90Y radioembolization?. Eur J Radiol. 2012; 81(12):3979-84. DOI: 10.1016/j.ejrad.2012.08.007. View

18.

Abdelmaksoud M, Hwang G, Louie J, Kothary N, Hofmann L, Kuo W . Development of new hepaticoenteric collateral pathways after hepatic arterial skeletonization in preparation for yttrium-90 radioembolization. J Vasc Interv Radiol. 2010; 21(9):1385-95. DOI: 10.1016/j.jvir.2010.04.030. View

19.

Kouri B . Interventional Oncology: Optimizing Transarterial Therapies for the Treatment of Hepatic Malignancy. Tech Vasc Interv Radiol. 2018; 21(4):205-222. DOI: 10.1053/j.tvir.2018.07.002. View

20.

Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, De Baere T . Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol. 2020; 6(1):17-29. DOI: 10.1016/S2468-1253(20)30290-9. View